Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.4831
-0.0880 (-15.41%)
At close: Nov 18, 2026, 4:00 PM EST
0.5001
+0.0170 (3.52%)
Pre-market: Nov 19, 2026, 7:07 AM EST
Celularity Market Cap
Celularity has a market cap or net worth of $15.68 million as of November 18, 2026. It is the 38,245th most valuable company in the world and the 5,240th biggest in the United States. Its market cap has decreased by 63.59% in one year.
Market Cap
15.68M
Enterprise Value
84.92M
1-Year Change
-63.59%
Global Rank
Country Rank
#5,240 United States
Category
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $15.68M, a decrease of -95.55%. That is a compound annual growth rate of -34.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 15.68M | -50.41% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 17.10M |
| Pasithea Therapeutics | 17.07M |
| Lipocine | 16.83M |
| NewcelX | 15.31M |
| Context Therapeutics | 15.29M |
| BioStem Technologies | 15.21M |
| Akari Therapeutics, | 15.20M |
| Seres Therapeutics | 14.68M |